midi health semaglutide does prescribe glp-1 The FDA has approved oral Wegovy—a daily pill option for weight loss that uses semaglutide, the same active ingredient as injectable GLP-1s. As Midi's Chief Medical Officer, Dr Semaglutide Injection for Seniors with

Side effects are generally mild, including nausea, diarrhea, or digestive discomfort

GLP-1 class safety monitoring should include awareness of these important risks: Pancreatitis : Patients should promptly report severe abdominal pain, with or without vomiting Gallbladder disease : Report symptoms of biliary colic or cholecystitis Acute kidney injury : Maintain adequate hydration, especially if experiencing nausea/vomiting Hypoglycemia : Increased risk when used with insulin or sulfonylureas Suicidal ideation : For patients using Wegovy or Zepbound, monitor for mood changes Patients should be counseled to report any neck swelling, difficulty swallowing, persistent hoarseness, or palpable thyroid nodules, as these warrant evaluation regardless of GLP-1 use

L.RizzoM

Ozempic is usually administered once a week via subcutaneous injection

Both are legitimate and effective